Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002704186 | SCV003735656 | uncertain significance | Inborn genetic diseases | 2021-07-13 | criteria provided, single submitter | clinical testing | The c.2867G>A (p.R956Q) alteration is located in exon 19 (coding exon 19) of the DHX16 gene. This alteration results from a G to A substitution at nucleotide position 2867, causing the arginine (R) at amino acid position 956 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003143571 | SCV003829102 | uncertain significance | Neuromuscular disease and ocular or auditory anomalies with or without seizures | 2021-09-17 | criteria provided, single submitter | clinical testing |